Literature DB >> 19629069

Signal integration by JNK and p38 MAPK pathways in cancer development.

Erwin F Wagner1, Angel R Nebreda.   

Abstract

Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) family members function in a cell context-specific and cell type-specific manner to integrate signals that affect proliferation, differentiation, survival and migration. Consistent with the importance of these events in tumorigenesis, JNK and p38 MAPK signalling is associated with cancers in humans and mice. Studies in mouse models have been essential to better understand how these MAPKs control cancer development, and these models are expected to provide new strategies for the design of improved therapeutic approaches. In this Review we highlight the recent progress made in defining the functions of the JNK and p38 MAPK pathways in different cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629069     DOI: 10.1038/nrc2694

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  161 in total

1.  The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis.

Authors:  O N Demidov; C Kek; S Shreeram; O Timofeev; A J Fornace; E Appella; D V Bulavin
Journal:  Oncogene       Date:  2006-10-02       Impact factor: 9.867

2.  Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis.

Authors:  Konrad Hochedlinger; Erwin F Wagner; Kanaga Sabapathy
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

3.  Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase.

Authors:  Gregory J Finn; Bernadette S Creaven; Denise A Egan
Journal:  Biochem Pharmacol       Date:  2004-05-01       Impact factor: 5.858

Review 4.  Activating p38 MAPK: new tricks for an old kinase.

Authors:  Paul R Mittelstadt; Jesús M Salvador; Albert J Fornace; Jonathan D Ashwell
Journal:  Cell Cycle       Date:  2005-09-20       Impact factor: 4.534

Review 5.  p38 MAP kinase: a convergence point in cancer therapy.

Authors:  James M Olson; Andrew R Hallahan
Journal:  Trends Mol Med       Date:  2004-03       Impact factor: 11.951

6.  JNK phosphorylates paxillin and regulates cell migration.

Authors:  Cai Huang; Zenon Rajfur; Christoph Borchers; Michael D Schaller; Ken Jacobson
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

7.  p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.

Authors:  Mi-Sung Kim; Eun-Jung Lee; Hyeong-Reh Choi Kim; Aree Moon
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice.

Authors:  Wataru Shibata; Shin Maeda; Yohko Hikiba; Ayako Yanai; Kei Sakamoto; Hayato Nakagawa; Keiji Ogura; Michael Karin; Masao Omata
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

9.  Chemical genetic analysis of the time course of signal transduction by JNK.

Authors:  Juan-Jose Ventura; Anette Hübner; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

Review 10.  Inhibitors of c-Jun N-terminal kinases: JuNK no more?

Authors:  Marie A Bogoyevitch; Peter G Arthur
Journal:  Biochim Biophys Acta       Date:  2007-10-11
View more
  922 in total

Review 1.  Fluoride's effects on the formation of teeth and bones, and the influence of genetics.

Authors:  E T Everett
Journal:  J Dent Res       Date:  2010-10-06       Impact factor: 6.116

2.  Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation.

Authors:  Eduard Sergienko; Jian Xu; Wallace H Liu; Russell Dahl; David A Critton; Ying Su; Brock T Brown; Xochella Chan; Li Yang; Ekaterina V Bobkova; Stefan Vasile; Hongbin Yuan; Justin Rascon; Sharon Colayco; Shyama Sidique; Nicholas D P Cosford; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Paul J Lombroso; Lutz Tautz
Journal:  ACS Chem Biol       Date:  2011-11-17       Impact factor: 5.100

Review 3.  [Malignancy potential of precursor lesions: determination using molecular markers].

Authors:  A Jung
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 4.  Controlling gene expression in response to stress.

Authors:  Eulàlia de Nadal; Gustav Ammerer; Francesc Posas
Journal:  Nat Rev Genet       Date:  2011-11-03       Impact factor: 53.242

5.  VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling.

Authors:  Isabel F Fernández; Luis G Pérez-Rivas; Sandra Blanco; Adrián A Castillo-Dominguez; José Lozano; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

6.  The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy.

Authors:  Yan-Ni Zhu; Guo-Jin Zuo; Qi Wang; Xiao-Ming Chen; Jin-Kui Cheng; Shu Zhang
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

7.  Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism.

Authors:  Amélie Vézina; Cyndia Charfi; Alain Zgheib; Borhane Annabi
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

8.  Rit-mediated stress resistance involves a p38-mitogen- and stress-activated protein kinase 1 (MSK1)-dependent cAMP response element-binding protein (CREB) activation cascade.

Authors:  Geng-Xian Shi; Weikang Cai; Douglas A Andres
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

9.  Local anesthetics induce apoptosis in human thyroid cancer cells through the mitogen-activated protein kinase pathway.

Authors:  Yuan-Ching Chang; Yi-Chiung Hsu; Chien-Liang Liu; Shih-Yuan Huang; Meng-Chun Hu; Shih-Ping Cheng
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

10.  A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.

Authors:  Kantima Leelahavanichkul; Panomwat Amornphimoltham; Alfredo A Molinolo; John R Basile; Sittichai Koontongkaew; J Silvio Gutkind
Journal:  Mol Oncol       Date:  2013-10-12       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.